Completed Trials

Gestational Diabetes

  • MIG

    • Gestational Diabetes
    • PHASE IV
    • 750 participants
    • 12 sites in New Zealand

    Gestational Diabetes; treatment with metformin compared with insulin. Sample size is 750 subjects to be recruited from centres in Australia and New Zealand. The trial is expected to be completed in 2-3 years.

    More about the MIG study

Trial Types

Benefits of conducting trials in New Zealand

  • Well established clinical trial infrastructure
  • Excellent recruitment and retention rates
  • High standard of medical practice
  • High standard of clinical trial data
  • Adherence to ICH/GCP and FDA regulations
  • Regulatory framework based on European and American systems

Learn more about conducting clinical trials in New Zealand